Posted inGenetics
Small Molecules to Big Partnership: Incyte, Genesis Expand AI Collaboration to $1B+
[L.-R.] Pablo J. Cagnoni, MD, Incyte’s president and global head of R&D, and Evan Feinberg, PhD, founder and CEO of…
Posted inGenetics
Cellares and TScan Agree to Evaluate Automated Manufacturing TSC-101 for Patients with Hematologic Malignancies
Credit: Jackyenjoyphotography/Getty Images IDMO Cellares and TScan Therapeutics will work together to evaluate automated clinical manufacturing of TSC-101, which is…
Posted inGenetics
New Antibiotic, Manikomycin, Acts on Novel Ribosomal Target
Ribosome [JUAN GAERTNER / Science Photo Library / Getty Images] Traditionally, antibiotic discovery has involved the isolation of natural products…
Posted inGenetics
NIIMBL to Support Vector Production and AI-Ready Training Projects
Viral vector production and training schemes designed to foster development of an AI-ready workforce dominate the list of projects selected…
Posted inGenetics
Bioproduction Pivots from Centralized to Regional Support
The global biopharma industry is placing increasing importance on regional support rather than only centralized expertise to help complex programs…
Posted inGenetics
Gentler Cell Separation Methods Gain Momentum
The race to commercialize cell therapies is forcing bioprocessing innovators to confront one of the field’s most persistent manufacturing bottlenecks:…
Posted inGenetics
Web App Helps Flag Antibodies Where Manufacturability Might Be an Issue
Researchers have developed an open-source web app to help drug manufacturers and developers identify unstable antibodies prone to aggregation. The…
Posted inGenetics
Immune Cell Phenotyping: Cell Surface Architecture Informs Disease Biology
The biophysical properties of the plasma membrane actively shape immune cell function, providing key insights into chronic disease and immune…
Posted inGenetics
Immune Response Activated by RNA Splicing Opens Targeted Therapies
RNA. [Christoph Burgstedt/Getty Images] In a new study published in Nature Communications titled, “Native long-read RNA sequencing of human monocytes reveals activation-induced…
Posted inGenetics
Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases
Robert Bell, PhD, chief scientific officer of Ascidian Therapeutics, and a colleague at work in the company’s Boston laboratory. Ascidian…